AI-generated summary
This review describes the molecular and cellular mechanisms of low level light therapy, which uses low levels of visible or near infrared light, and discusses a biphasic dose response in which lower light levels often work better than higher ones. The authors also describe their recent in vitro and in vivo results that they report provide scientific explanations for this pattern. The abstract notes that the biochemical mechanisms are incompletely understood and that the field remains controversial in mainstream medicine.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract is a narrative review that does not report pooled or quantified results, and the mechanisms are described as incompletely understood.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Biphasic dose response, Dose, Low-level laser therapy, Light-emitting diode, Inflammation, Wavelength, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.